AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Aura Minerals, you need to believe the company can turn today’s high cost production into a more efficient, growing portfolio as projects like MSG and Borborema mature. The latest Q2 update, with slightly weaker output but reaffirmed full year guidance, keeps the near term focus squarely on whether MSG’s integration really delivers the second half production and cost improvements Aura is counting on, making execution risk at MSG the key swing factor.
Against that backdrop, Aura’s recent approval of a US$200,000,000 share repurchase program stands out. It signals management’s willingness to deploy balance sheet capacity toward shareholder returns at the same time it is investing heavily in growth projects like Borborema and Era Dorada. For investors watching the production ramp and AISC trend, this capital allocation choice sits right beside MSG’s turnaround as a key catalyst to reassess how Aura balances growth, risk and returns.
Yet while Aura talks up a second half recovery, investors should also be aware that...
Read the full narrative on Aura Minerals (it's free!)
Aura Minerals' narrative projects $2.3 billion revenue and $1.0 billion earnings by 2029. This requires 26.6% yearly revenue growth and an increase in earnings of about $0.9 billion from $89.1 million today.
Uncover how Aura Minerals' forecasts yield a $95.16 fair value, a 68% upside to its current price.
By contrast, the most optimistic analysts were assuming revenue could reach about US$3.1 billion and earnings US$1.5 billion by 2029, so this softer Q2 and the MSG execution risk they highlighted could easily reshape those projections and is a good reminder that your view might differ from theirs.
Explore 5 other fair value estimates on Aura Minerals - why the stock might be worth over 5x more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com